InventionMed S.A. (WSE:INM)
Poland · Delayed Price · Currency is PLN 0.1060
+0.0005 (0.47%)
At close: Jun 15, 2026
InventionMed Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.74 | 3.17 | 0.28 | 0 | 0 | 0.01 | |
Revenue Growth (YoY) | 684.24% | 1041.56% | 45810.74% | -85.12% | -61.10% | 100.96% |
Cost of Revenue | 0.14 | 0.26 | 0.18 | 0.01 | 0.01 | 0.01 |
Gross Profit | 3.6 | 2.91 | 0.1 | -0.01 | -0 | 0.01 |
Selling, General & Admin | 1.15 | 1.72 | 2.13 | 1.45 | 1.32 | 1.08 |
Other Operating Expenses | -0.59 | -0.52 | -0.41 | -1.4 | -0.6 | -0.47 |
Operating Expenses | 1.45 | 2.09 | 2.57 | 1.15 | 0.75 | 0.68 |
Operating Income | 2.15 | 0.82 | -2.47 | -1.17 | -0.75 | -0.67 |
Interest Expense | -1.54 | -1.6 | -1.54 | -0.82 | -0.33 | -0 |
Interest & Investment Income | 0 | 0.05 | 0 | - | - | - |
Other Non Operating Income (Expenses) | -0.01 | -0.02 | - | -0 | -0.01 | - |
EBT Excluding Unusual Items | 0.59 | -0.75 | -4 | -1.99 | -1.1 | -0.67 |
Gain (Loss) on Sale of Investments | - | - | -0.4 | - | -21.12 | - |
Gain (Loss) on Sale of Assets | - | - | - | 0.1 | 0.06 | - |
Pretax Income | 0.59 | -0.75 | -4.41 | -1.89 | -22.15 | -0.67 |
Net Income | 0.59 | -0.75 | -4.41 | -1.89 | -22.15 | -0.67 |
Net Income to Common | 0.59 | -0.75 | -4.41 | -1.89 | -22.15 | -0.67 |
Shares Outstanding (Basic) | 203 | 203 | 203 | 203 | 203 | 203 |
Shares Outstanding (Diluted) | 203 | 203 | 203 | 203 | 203 | 203 |
EPS (Basic) | 0.00 | -0.00 | -0.02 | -0.01 | -0.11 | -0.00 |
EPS (Diluted) | 0.00 | -0.00 | -0.02 | -0.01 | -0.11 | -0.00 |
Free Cash Flow | -0.71 | -1.08 | 0.7 | -14.88 | -6.36 | 4.54 |
Free Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.07 | -0.03 | 0.02 |
Gross Margin | 96.17% | 91.83% | 35.13% | - | -58.84% | 50.23% |
Operating Margin | 57.36% | 25.80% | -889.34% | -192602.65% | -18565.76% | -6450.20% |
Profit Margin | 15.82% | -23.64% | -1586.13% | -312258.35% | -545002.61% | -6450.38% |
Free Cash Flow Margin | -18.86% | -34.05% | 250.42% | -2459759.83% | -156521.01% | 43450.64% |
EBITDA | 3.04 | 1.71 | -1.62 | -0.07 | -0.72 | -0.61 |
EBITDA Margin | 81.33% | 53.81% | - | - | - | - |
D&A For EBITDA | 0.9 | 0.89 | 0.85 | 1.1 | 0.03 | 0.07 |
EBIT | 2.15 | 0.82 | -2.47 | -1.17 | -0.75 | -0.67 |
EBIT Margin | 57.36% | 25.80% | - | - | - | - |
Revenue as Reported | 3.74 | 3.17 | 0.28 | 0 | 0 | 0.01 |